Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-mixed versus sequential intrathecal fentanyl with hyperbaric bupivacaine for cesarean delivery
PACTR202205853184065Phase 3Unknown
- Sponsor
- Dilla University
- Start
- Apr 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of fentanyl and bupivacaine in postoperative pain and None (2 arms), sponsored by Dilla University. Primary endpoint: Hemodynamic and analgesic effectiveness. Status: unknown.
02
Drugs
fentanylbupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202205853184065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202205853184065.